STING1 and liver cancer: Taken together, these results indicated that the synergistic effect of ROD hydrogel promoted the recruitment and maturation of imDCs, activated the cGAS/STING/IFN-I pathway, enhanced the antitumor immunity, and thus improved the treatment efficacy against residual liver cancer after iRFA therapy.